Technology
Most Popular Under $25
100 Most Popular

Viking Therapeutics

29,035

$8.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.25%) Today
+$0.04 (+0.50%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell VKTX and other stocks, options, ETFs, and crypto commission-free!

About VKTX

Viking Therapeutics, Inc. Common Stock, also called Viking Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Read More The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

CEO
Brian Lian
Employees
15
Headquarters
San Diego, California
Founded
2012
Market Cap
577.39M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.71M
High Today
$8.16
Low Today
$7.92
Open Price
$8.12
Volume
1.04M
52 Week High
$12.62
52 Week Low
$6.15

Collections

Technology
Most Popular Under $25
100 Most Popular
Health
Biotechnology
Medical
Therapy
Biopharmaceutical

VKTX Earnings

-$0.13
-$0.11
-$0.09
-$0.07
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.13 per share
Actual
-$0.08 per share
Replay Earnings Call

You May Also Like

FXY
FIHD
GGT
DGT
ADNT
IGHG
HCI
NFLX
CMU
SBBP
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy VKTX

Market Price$8.05
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell VKTX stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up